CPA1 and myeloid sarcoma: However, an increase in cpa prevalence in the MS group (etx– and etx+ combined) compared with the HC group (Figure 2C) suggests that people with MS may have a more suitable gastrointestinal environment for the survival and growth of C. perfringens.